-
New Method Rejuvenates Skin Cells, Signaling Potential Transformation in Regenerative Medicine
British scientists at the Babraham Institute have developed a groundbreaking technique called "maturation phase transient reprogramming" that reverses aging in human skin cells. By exposing aged skin cells to Yamanaka factors (a set of four transcription factors) for 13 days, the cells regain youthful characteristics, including increased collagen production and enhanced wound-healing capabilities.
넶0 2024-10-12 -
SanBio 的 AKUUGO® 颅内植入悬浮液获日本有条件上市批准
2024 年 7 月 31 日，SanBio 宣布其开发的 “AKUUGO® 颅内植入悬浮液” 在日本获得有条件上市批准，用于改善创伤性脑损伤（TBI）引起的慢性运动瘫痪。这是全球首款获批用于此适应症的同种异体细胞治疗药物。
넶19 2024-10-12 -
FDA 加速审批 Rexlemestrocel-L 为慢性心力衰竭治疗带来新希望
2024 年 3 月，Mesoblast 公司宣布 FDA 支持 Rexlemestrocel - L 用于终末期射血分数降低和植入左心室辅助装置心衰患者的加速批准申请。
넶23 2024-10-12
